| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2852734-46-2 | Edoxaban (RRR)-Isomer Tosylate | C31H38ClN7O7S2 |
| 2865162-09-8 | Benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-YL)-6-(1-methoxyethyl)pyridin-3-YL)piperazine-1-carboxylate | C35H43BrN4O4 |
| 2865162-15-6 | (S)-3-(5-bromo-2-(2-(1-methoxyethyl)pyridin-3-yl)-1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)-2,2-dimethylpropan-1-ol | C23H26BrF3N2O2 |
| 2869954-34-5 | Werner syndrome RecQ helicase-IN-1 | C31H31ClF3N9O5 |
| 2871770-04-4 | (S,Z)-(2-(Fluoromethylene)tetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol hydrochloride | C9H15ClFNO |
| 2875067-31-3 | (R)-4,4,4-Trifluoro-3-hydroxy-3-methylbutan-2-one | C5H7F3O2 |
| 2883234-39-5 | Cartegravir Impurity 09 | C19H17F2N3O5 |
| 2889432-05-5 | Minoxidil Impurity 3 | C9H14ClN5O |
| 2892260-32-9 | N-Nitroso Sitagliptin Impurity | C6H6F3N5O |
| 2915356-76-0 | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH | C66H105N5O16 |
| 2922526-56-3 | (4-(3,6-Dimethoxy-9h-carbazol-9-yl)butyl)phosphonic acid | C18H22NO5P |
| 2922732-54-3 | RMC-9805 | C63H88F3N11O7 |
| 2924842-16-8 | tert-butyl (3R)-3-[(2S)-3-[3-(2-aminoethoxy)phenyl]-1-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]pyrrolidine-1-carboxylate | C24H38N2O5 |
| 2937344-16-4 | BI-2493 | C24H27N7OS |
| 2940879-42-3 | 1-[5-bromo-6-[(1S)-1-methoxyethyl]-3-pyridyl]-4-methyl-piperazine | C13H20BrN3O |
| 2941535-53-9 | 6-Chloro-7-methoxy-1H-pyrazolo[4,3-c]pyridine | C7H6ClN3O |
| 2952660-99-8 | tert-butyl (2-fluoro-5-hydroxy-4-methoxyphenyl)carbamate | C12H16FNO4 |
| 2971088-37-4 | (4-(2,7-Dibromo-9,9-dimethylacridin-10(9H)-yl)butyl)phosphonic acid | C19H22Br2NO3P |
| 2991356-61-5 | 4-bromo-5-fluoro-6-nitro-1(3H)-Isobenzofuranone | C8H3BrFNO4 |
| 3034241-44-3 | (S)-2,3-Bis(tert-butoxycarbonyl)-2,3-diazabicyclo[3.1.1]heptane-4-carboxylic acid | C16H26N2O6 |
| 3046309-17-2 | MeO-PhPACz | C20H18NO5P |